Treating metastatic cancer with nanotechnology
Treating metastatic cancer with nanotechnology
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
In most patients, by the time cancer is detected, metastasis has already occurred. More than 80% of patients diagnosed with lung cancer, for example, present with metastatic disease.
Nanotechnology is not alien to the clinic; more than 40 nanotherapeutics have reached patients, including anticancer drugs and imaging agents.
Many...
Alternative Titles
Full title
Treating metastatic cancer with nanotechnology
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1014101211
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1014101211
Other Identifiers
ISSN
1474-175X
E-ISSN
1474-1768
DOI
10.1038/nrc3180
